Editorial: Dynamics of endocrine system dysfunctions and neuro-ophthalmic manifestations: early diagnostic to therapeutic implications

• by Kumar, Dhiraj , Naqvi, Ahmad Abu Turab , Gupta, Rohan , Kumari, Smita , Waseem, Rashid , Hassan, Md. Imtaiyaz

• May 31, 2026

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

• by Kathryn Wighton

• July 31, 2026

• 3 min

Zinc, type 2 diabetes, diabetic kidney disease: focus on hypoxia

• by Svetlana A. Lebedeva, Ekaterina M. Mikhailova, Maria Yu Materenchuk, Denis V. Kurkin, Mikhail Samsonov, Vadim V. Tarasov, Kerim Mutig

• July 21, 2026

Can Endotoxin-Targeted Care Improve Sepsis Outcomes?

Biomarker-guided patient selection may help identify patients with sepsis who could benefit from endotoxin-targeted therapy, although confirmatory evidence is still needed.

• by Andrea Surnit

• July 20, 2026

• 3 min